Published April 2005
| Version v1
Journal article
Phase II study of radiochemotherapy with vinblastine in invasive bladder cancer
- 1. Department of Radiation Therapy, Institute of Oncology, Ljubljana (Slovenia)
- 2. Department of Public Health, Ljubljana University School of Medicine (Slovenia)
- 3. Department of Urology, University Medical Centre, Ljubljana (Slovenia)
- 4. Department of Clinical Oncology, Institute of Oncology, Ljubljana (Slovenia)
Description
Concurrent vinablastine-based radiochemotherapy was evaluated in 84 bladder-cancer patients. It was effective in more than half: tumour-specific survival (51% 9-year), local control rate (55% 9-year). The drawback was the impaired function of the bladder (9-year prevalence SOMA G3-4 symptoms: 66%), indicating the need for treatment aimed at reducing chronic morbidity
Additional details
Identifiers
- DOI
- 10.1016/j.radonc.2005.01.007;
- PII
- S0167-8140(05)00053-8;
Publishing Information
- Journal Title
- Radiotherapy and Oncology
- Journal Volume
- 75
- Journal Issue
- 1
- Journal Page Range
- p. 44-47
- ISSN
- 0167-8140
- CODEN
- RAONDT
INIS
- Country of Publication
- Ireland
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 37018775
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BLADDER; CARCINOMAS; CHEMOTHERAPY; PATIENTS; RADIOTHERAPY; SYMPTOMS; VINBLASTINE
- Descriptors DEC
- ALKALOIDS; ANTIMITOTIC DRUGS; AROMATICS; AZAARENES; AZOLES; BODY; DISEASES; DRUGS; HETEROCYCLIC COMPOUNDS; INDOLES; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; ORGANIC COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; ORGANS; PYRROLES; RADIOLOGY; THERAPY; URINARY TRACT
Optional Information
- Copyright
- Copyright (c) 2005 Elsevier Science B.V., Amsterdam, Netherlands, All rights reserved.